Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease.
Buhl S, Steenholdt C, Brynskov J, Christensen KR, Dorn-Rasmussen M, Thomsen OØ, Bendtzen K, Klausen TW, Dahlerup JF, Thorsgaard N, Jahnsen J, Molazahi A, Pedersen N, Kjeldsen J, Almer S, Dahl EE, Vind I, Cannon AG, Marsal J, Sipponen T, Agnholt JS, Kievit HAL, Aure SL, Martinsen L, Meisner S, Hansen JM, Ainsworth MA. Buhl S, et al. Among authors: ainsworth ma. NEJM Evid. 2022 Aug;1(8):EVIDoa2200061. doi: 10.1056/EVIDoa2200061. Epub 2022 Jun 14. NEJM Evid. 2022. PMID: 38319804 Clinical Trial.
Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis.
Katibian DJ, Solitano V, Polk DB, Nguyen T, Ma C, Syal G, Kobayashi T, Hibi T, Buhl S, Ainsworth MA, Jairath V, Singh S. Katibian DJ, et al. Among authors: ainsworth ma. Clin Gastroenterol Hepatol. 2024 Jan;22(1):22-33.e6. doi: 10.1016/j.cgh.2023.08.039. Epub 2023 Sep 15. Clin Gastroenterol Hepatol. 2024. PMID: 37716619 Review.
Exploring disease-related and treatment-related issues and concerns experienced by adults with spondyloarthritis, inflammatory bowel disease and psoriasis to identify unmet needs: a qualitative clinical concept mapping study.
Stisen ZR, Skougaard M, Christensen KR, Ainsworth MA, Hansen RL, Thomsen SF, Mogensen M, Dreyer L, Kristensen LE, Jørgensen TS. Stisen ZR, et al. Among authors: ainsworth ma. BMJ Open. 2023 Dec 11;13(12):e071586. doi: 10.1136/bmjopen-2023-071586. BMJ Open. 2023. PMID: 38081674 Free PMC article.
Fatigue is a systemic extraintestinal disease manifestation largely independent of disease activity, chronicity, and nutritional deficiencies in inflammatory bowel disease on biologics.
Christensen KR, Ainsworth MA, Steenholdt C, Buhl S, Skougaard M, Brynskov J, Jørgensen TS, Kristensen LE. Christensen KR, et al. Among authors: ainsworth ma. Scand J Gastroenterol. 2022 Sep;57(9):1051-1057. doi: 10.1080/00365521.2022.2060049. Epub 2022 Apr 12. Scand J Gastroenterol. 2022. PMID: 35412932
Drug Levels Associated With Optimal Discrimination Between Remission and Nonremission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease.
Dorn-Rasmussen M, Buhl S, Brynskov J, Bay JT, Bolstad N, Klausen TW, Warren DJ, Ainsworth MA, Steenholdt C. Dorn-Rasmussen M, et al. Among authors: ainsworth ma. Ther Drug Monit. 2022 Apr 1;44(2):290-300. doi: 10.1097/FTD.0000000000000913. Ther Drug Monit. 2022. PMID: 34387220
100 results